LG
UTHR icon

Leuthold Group’s United Therapeutics UTHR Stock Holding History

Leuthold Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.37M Buy
10,736
+64
+0.6% +$31.9K 0.68% 51
2025
Q4 		$5.2M Buy
10,672
+3,126
+41% +$1.46M 0.56% 69
2025
Q3 		$3.16M Buy
+7,546
New +$2.54M 0.35% 110
2016
Q2 		– Sell
-31,789
Closed -$3.54M – 248
2016
Q1 		$3.54M Buy
31,789
+632
+2% +$80K 0.39% 99
2015
Q4 		$4.88M Buy
31,157
+1,457
+5% +$212K 0.51% 80
2015
Q3 		$3.9M Sell
29,700
-3,783
-11% -$607K 0.41% 93
2015
Q2 		$5.82M Buy
33,483
+1,508
+5% +$271K 0.54% 57
2015
Q1 		$5.51M Buy
31,975
+113
+0.4% +$17.2K 0.51% 70
2014
Q4 		$4.13M Buy
+31,862
New +$4.11M 0.41% 93
2013
Q4 		– Sell
-13,420
Closed -$1.06M – 293
2013
Q3 		$1.06M Sell
13,420
-1,618
-11% -$118K 0.1% 224
2013
Q2 		$990K Buy
+15,038
New +$969K 0.09% 239

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Leuthold Group's UTHR Position: Q1 2026 in Review

Leuthold Group increased its United Therapeutics (UTHR) stake by 0.6% in Q1 2026, buying an estimated $31.9K and bringing the position to 10,736 shares worth $6.37M. The position accounts for 0.68% of the portfolio, ranked #51.

Leuthold Group first reported a position in UTHR in Q2 2013 and has held it in 11 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Leuthold Group held 10,736 shares of United Therapeutics worth $6.37M as of Q1 2026.
  • Leuthold Group bought 64 United Therapeutics shares in Q1 2026, an estimated $31.9K.
  • United Therapeutics made up 0.68% of Leuthold Group's portfolio in Q1 2026, its #51 holding.
  • Leuthold Group first reported a position in United Therapeutics in Q2 2013 and has held it in 11 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Leuthold Group's 13F filing for Q1 2026, filed 6 May 2026.